Floatz logo

Fludarabine

B-cell Adult Acute Lymphoblastic Leukemia

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 2Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the B-cell Adult Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
The First Affiliated Hospital of Soochow University
Phase 3BBB
Calcium folinate pentahydrate
Mayo Clinic
Phase 3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mayo Clinic
Phase 2BB
ASPARAGINASE
National Cancer Institute (NCI)
Phase 2BB
FILGRASTIM
National Cancer Institute (NCI)
Phase 2BB

View all 39 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →